Company Listing
Lombard Medical

Lombard Medical is developing solutions for the $1.1 billion dollar abdominal aortic aneurysm (AAA) repair market. AAAs are balloon-like enlargements of the aorta which, if left untreated, may rupture and cause death. The company’s lead product, an endovascular stent graft that has been specifically designed to solve the problems that exist in treating complex tortuous anatomy, is approved in the US, Europe and Japan. Lombard is a VIPE (Venture Investment in Public Equity).

BACK
Location
Didcot, UK
CEO
Simon Hubbert
Abingworth Partner
Tim Haines
Website Address

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
Company Listing

Lombard Medical is developing solutions for the $1.1 billion dollar abdominal aortic aneurysm (AAA) repair market. AAAs are balloon-like enlargements of the aorta which, if left untreated, may rupture and cause death. The company’s lead product, an endovascular stent graft that has been specifically designed to solve the problems that exist in treating complex tortuous anatomy, is approved in the US, Europe and Japan. Lombard is a VIPE (Venture Investment in Public Equity).

Location
Didcot, UK
CEO
Simon Hubbert
Abingworth Partner
Tim Haines
Website Address
BACK
 
Copyright Abingworth 2017